Skip to content

ImageneBio, Inc.

IMA· NasdaqCore metricsCIK 1835579

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -5.99%
Market cap
$44.97M
12.46M shares
Filings
339
$800.00K
FY 2025−77.1% FY25 yoy
-$15.62M
Q3 2026N/M FY25 yoy
-$17.31M
Q3 2026N/M FY25 yoy
-$80.16M
FY 2023derivedN/M FY23 yoy
-$0.91
Q3 2026N/M FY25 yoy
$84.85M
Q3 2026+680.1% FY25 yoy
$44.97M
—
56.2×
0.4×
—
—

FY2025 figures · derived

Price

$3.6158.41%$5.07past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$800.00KFY 2025
$30.99M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$800,000reported
FY 20242024-12-31$3,500,000reported
FY 20232023-12-31$9,160,000reported
FY 20222022-12-31$15,618,000reported
FY 20212021-12-31$30,985,000reported
FY 20202020-12-31$9,194,000reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$663.00K$663.00K—48.26M sh+33.1%—

Biological products, except diagnostic substances

ImageneBio, Inc. is the 81st largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR